- Home
- SR vs MRUS Comparison
SR vs MRUS Comparison
Compare SR & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SR
- MRUS
- Stock Information
- Founded
- SR 1857
- MRUS 2003
- Country
- SR United States
- MRUS Netherlands
- Employees
- SR N/A
- MRUS N/A
- Industry
- SR Oil/Gas Transmission
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- SR Utilities
- MRUS Health Care
- Exchange
- SR Nasdaq
- MRUS Nasdaq
- Market Cap
- SR 4.3B
- MRUS 4.1B
- IPO Year
- SR N/A
- MRUS 2016
- Fundamental
- Price
- SR $75.75
- MRUS $54.99
- Analyst Decision
- SR Buy
- MRUS Strong Buy
- Analyst Count
- SR 9
- MRUS 13
- Target Price
- SR $79.56
- MRUS $88.54
- AVG Volume (30 Days)
- SR 472.2K
- MRUS 637.7K
- Earning Date
- SR 07-30-2025
- MRUS 07-31-2025
- Dividend Yield
- SR 4.13%
- MRUS N/A
- EPS Growth
- SR N/A
- MRUS N/A
- EPS
- SR 4.09
- MRUS N/A
- Revenue
- SR $2,428,300,000.00
- MRUS $54,732,000.00
- Revenue This Year
- SR $1.50
- MRUS $68.08
- Revenue Next Year
- SR $5.13
- MRUS $0.09
- P/E Ratio
- SR $18.55
- MRUS N/A
- Revenue Growth
- SR N/A
- MRUS 42.77
- 52 Week Low
- SR $61.56
- MRUS $33.19
- 52 Week High
- SR $79.81
- MRUS $62.98
- Technical
- Relative Strength Index (RSI)
- SR 62.37
- MRUS 56.61
- Support Level
- SR $73.28
- MRUS $51.78
- Resistance Level
- SR $74.66
- MRUS $56.60
- Average True Range (ATR)
- SR 1.24
- MRUS 1.70
- MACD
- SR 0.29
- MRUS -0.01
- Stochastic Oscillator
- SR 80.26
- MRUS 66.60
About SR Spire Inc.
Spire Inc is a public utility holding company with three reportable business segments: Gas Utility, Gas Marketing and Midstream. The Gas Utility segment includes the regulated operations of Laclede Gas, Alabama Gas Corporation ('Alagasco') changed its name to Spire Alabama Inc. effective September 1, 2017, and Laclede Gas Company changed its name to Spire Missouri Inc. effective August 30, 2017. The Gas Utility segment generates a majority of the company's revenue but is subject to seasonal fluctuations. The Gas Marketing segment includes Laclede Energy Resources, Inc, whose operations include the marketing of natural gas and related activities on a non-regulated basis and the Midstream segment includes transportation and storage of natural gas. Maximum revenue from residential area.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.